| Sketches of Strength, Chapter 3 - A Love Story |
|
|
| Written by Dr. Mel | ||||
| Sunday, 26 March 2006 | ||||
Page 1 of 2 December 1989. I could never forget that month. The average temperature was just 18 degrees in Connecticut, and that was the coldest December on record. The temperature was a good 10 degrees below “normal,” and if that difference were to be maintained over a long period, those thoughts of global warming would just be iced over memories. A major glacial advance would get underway. We would experience a new ice age!
Almost daily, the temperature hovered near or below zero, and the entire landscape was encased in ice. I was even called to testify about the heinous nature of a murder that was committed during that month, based upon the brutal cold. But through it all, there was warmth in the air, and during that harsh month, Beth Renee Davis and Ira Elliot Wolmer were married on December 16th at Beth Jacob Synagogue in Norwich, Ct.
|
||||
| < Prev | Next > |
|---|
Multiple Myeloma News Update
-

The AgeWhat's Ailing Steve Jobs? Medical Opinion Varies
TIME - 4 hours ago
If a patient were losing the proteins through urine, diabetes could be an explanation, but so could other conditions, including multiple myeloma, ...
Video: Steve Jobs Weight Loss Due to Hormone Imbalance AssociatedPress
Wired speculates about Apple CEO Steve Jobs’ urination, defecation ... MacDailyNews
Typical Apple: Jobs' Health Message Heavy on Meaning, Light on Detail Wired News
all 2,659 news articles -
Facet Biotech chief business officer ‘terminated’ Silicon Valley ...
Bizjournals.com, NC - 5 hours ago
Among Facet’s assets is the Phase I multiple myeloma drug elotuzumab. Shah’s base salary last year was $325000. With salary, bonus, the value of stock and ... -
27th Annual JP Morgan Healthcare Conference
Business Wire (press release), CA - 13 hours ago
ACE-011 is currently being studied in a Phase 2 trial in multiple myeloma patients with osteolytic bone disease. ACE-011 is being jointly developed by ... -
Health Notes
Buffalo News, United States - 15 hours ago
... Gilda’s Club WNY, 834-2578; multiple myeloma family, 6 pm Thursday, Roswell Park Cancer Institute, preregistration necessary for new members, 834-2578; ... -
Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 ...
Reuters - Jan 5, 2009
... I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman's disease, or multiple myeloma. ... -
Zacks Analyst Blog Highlights:Celgene Corp., Cytori Therapeutics ...
Reuters - Jan 5, 2009
... dominated by Celgene with complementary Vidaza and Revlimid, although Revlimid and Thalomid face tough competition in the multiple myeloma (MM) market. ... -
Mozobil approved for non-Hodgkin’s lymphoma and multiple myeloma
Prescribing Reference, New York - Dec 18, 2008
... to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). ... -
Multiple Myeloma Research Foundation Executive Director and Chief ...
MarketWatch - Dec 17, 2008
ADVISORY, Dec 17, 2008 (GlobeNewswire via COMTEX) -- What: Scott Santarella, Executive Director and COO of the Multiple Myeloma Research Foundation, ...
Multiple Myeloma Research Foundation Executive Director and Chief ... MSNBC
all 11 news articles












